EBV INFECTION AFTER ALLOGENIC HSCT

Clinical trials for EBV INFECTION AFTER ALLOGENIC HSCT explained in plain language.

Never miss a new study

Get alerted when new EBV INFECTION AFTER ALLOGENIC HSCT trials appear

Sign up with your email to follow new studies for EBV INFECTION AFTER ALLOGENIC HSCT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells tested to fight deadly Post-Transplant virus

Disease control Recruiting now

This early-stage study is testing a new cell therapy for patients who develop a dangerous Epstein-Barr virus (EBV) infection after a stem cell transplant. Doctors take T cells from the transplant donor, engineer them in a lab to specifically target the EBV virus, and then infuse …

Matched conditions: EBV INFECTION AFTER ALLOGENIC HSCT

Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control

Last updated Apr 04, 2026 06:50 UTC

EBV INFECTION AFTER ALLOGENIC HSCT

Get alerted when new EBV INFECTION AFTER ALLOGENIC HSCT trials appear

Engineered immune cells tested to fight deadly Post-Transplant virus